Publication | Closed Access

Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a double-blind, randomised, placebo-controlled, phase 3, superiority trial

Superiority TrialPulmonary CareAntibioticsRespiratory InfectionInfectious Respiratory DiseaseGram-negative PneumoniaPulmonary MedicineMedicineAntimicrobial ResistancePhase 3